However, patients having tumours expressing high HER1 together with high expressions of HER3 and HER4 had a better survival (Figure 2A) compared to the patients expressing high HER1 but low expression of HER3 and HER4 (P=0.0006) (Figure 2A, compare a with e). This evidence concerns the gene ERBB4 and neoplasm.